Journals

SHALDAM, M., D. HENDRYCHOVA, R. EL-HAGGAR, V. VOJÁČKOVÁ, T. MAJRASHI, E. ELKAEED, N. MASURIER, V. KRYŠTOF, H. TAWFIK, W. ELDEHNA

2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. European Journal of Medicinal Chemistry. 2023, 258, 115610, ISSN: 0223-5234, PMID: 37437350, PDF.

JESETA, M., A. POSPISILOVA, L. MEKINOVA, K. FRANZOVA, P. VENTRUBA, E. LOUSOVA, B. KEMPISTY, T. OŽDIAN, J. ZAKOVA, I. CRHA

Non-Invasive Diagnostics of Male Spermatogenesis from Seminal Plasma: Seminal Proteins. Diagnostics (Basel, Switzerland). 2023, 13(15), 2468, ISSN: 2075-4418, PMID: 37568830, PDF.

HRUBÁ, L., V. DAS, M. HAJDÚCH, P. DŽUBÁK

Nucleoside-based anticancer drugs: mechanism of action and drug resistance. Biochemical Pharmacology. 2023, ISSN: 0006-2952 , PMID: 37567317, PDF.

WAZYNSKA, M., R. BUTERA, M. REQUESENS, A. PLAT, T. ZARGANES-TZITZIKAS, C. NEOCHORITIS, J. PLEWKA, L. SKALNIAK, J. KOCIK-KROL, B. MUSIELAK, K. MAGIERA-MULARZ, I. RODRIGUEZ, S. BLOK, M. DE BRYUN, H. NIJMAN, P. ELSINGA, T. HOLAK, A. DÖMLING

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors. Journal of Medicinal Chemistry. 2023, 66(14), 9577-9591, ISSN: 0022-2623, PMID: 37450644,

MOUDRÝ, P., C. LUKAS, L. MACUREK, H. HANZLIKOVA, Z. HODNY, J. LUKÁŠ, J. BÁRTEK

Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage. Cell Cycle. 2012, 11(8), 1573-1582, ISSN: 1538-4101, PMID: 22456334,

BALIK, V., J. SROVNAL, I. SULLA, O. KALITA, T. FOLTANOVÁ, M. VAVERKA, L. HRABALEK, M. HAJDÚCH

MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas. Journal of Neuro-Oncology. 2013, 112(1), 1-8, ISSN: 0167-594X, PMID: 23307326,

LAKOMÝ, R., J. ŠÁNA, S. HANKEOVÁ, P. FADRUS, L. KREN, E. LZICAROVA, M. SVOBODA, H. DOLEZELOVA, M. SMRCKA, R. VYZULA, M. HAJDÚCH, O. SLABÝ

MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Science. 2011, 102(12), 2186-2190, ISSN: 1347-9032, PMID: 21895872,

FRIEDECKÝ, D., K. MIČOVÁ, E. FABER, M. HRDA, J. ŠIROKÁ, T. ADAM

Detailed study of imatinib metabolization using high-resolution mass spectrometry. Journal of Chromatography. 2015, 1409(-), 173-181, ISSN: 0021-9673, PMID: 26199102,

DAS, V., F. BRUZZESE, P. KONEČNÝ, F. IANNELLI, A. BUDILLON, M. HAJDÚCH

Pathophysiologically relevant in vitro tumor models for drug screening. Drug Discovery Today. 2015, 20(7), 848-55, ISSN: 1359-6446, PMID: 25908576,

CHROMÁ, M., K. HRICOVÁ, M. KOLÁŘ, P. SAUER, D. KOUKALOVA

Using newly developed multiplex polymerase chain reaction and melting curve analysis for detection and discrimination of β-lactamases in Escherichia coli isolates from intensive care patients. Diagnostic Microbiology and Infectious Disease. 2011, 71(3), 181-191, ISSN: 0732-8893, PMID: 21856106,